Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/19322968211013369 http://scihub22266oqcxt.onion/10.1177/19322968211013369 34159841!8442178!34159841     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Diabetes+Sci+Technol 2021 ; 15 (5): 1181-1187 Nephropedia Template TP {{tp|p=34159841|t=2021. Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia |pdf=|usr=}}{{34159841}} gab.com Text Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia JO: J Diabetes Sci Technol http://www.kidney.de/pget.php?&tw=1&pmid=34159841 #FOAvip Complications of Coronavirus Disease 2019 (COVID-19) occur with increased frequency in people admitted to the hospital with diabetes or hyperglycemia. The increased risk for COVID-19 infections in the presence of these metabolic conditions is in part due to overlapping pathophysiologic features of COVID-19, diabetes, and glucose control. Various antiviral treatments are being tested in COVID-19 patients. We believe that in these trials, it will be useful to evaluate treatment effect differences in patients stratified according to whether they have diabetes or hyperglycemia. In this way, it will be possible to better facilitate development of antiviral treatments that are most specifically beneficial for the large subset of COVID-19 patients who have diabetes or hyperglycemia. Twit Text FOAVip Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia ????J Diabetes Sci Technol http://www.kidney.de/pget.php?&tw=1&pmid=34159841 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34159841 #FOAvip English Wikipedia <ref>{{Cite pmid|34159841}}</ref> Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia #MMPMID34159841 Klonoff DC; Messler J; Valk T; Jagannathan R; Pasquel FJ; Umpierrez GE J Diabetes Sci Technol 2021[Sep]; 15 (5): 1181-1187 PMID34159841show ga Complications of Coronavirus Disease 2019 (COVID-19) occur with increased frequency in people admitted to the hospital with diabetes or hyperglycemia. The increased risk for COVID-19 infections in the presence of these metabolic conditions is in part due to overlapping pathophysiologic features of COVID-19, diabetes, and glucose control. Various antiviral treatments are being tested in COVID-19 patients. We believe that in these trials, it will be useful to evaluate treatment effect differences in patients stratified according to whether they have diabetes or hyperglycemia. In this way, it will be possible to better facilitate development of antiviral treatments that are most specifically beneficial for the large subset of COVID-19 patients who have diabetes or hyperglycemia. |*Clinical Trials as Topic/methods/statistics & numerical data[MESH] |*Diabetes Mellitus/blood/epidemiology/therapy[MESH] |*Hyperglycemia/blood/epidemiology/therapy[MESH] |Antiviral Agents/therapeutic use[MESH] |Blood Glucose/metabolism[MESH] |COVID-19/blood/complications/*epidemiology/*therapy[MESH] |Data Accuracy[MESH] |Hospitalization/statistics & numerical data[MESH] |Humans[MESH] |Research Design[MESH] |Risk Factors[MESH]Clinical Trials of COVID-19 Therapies Should Account for Diabetes and (epmc).pdf DeepDyve Pubget Overpricing